Related Experiment Video
Updated: Nov 23, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Status of cardiovascular surgery in Japan: A report based on the Japan Cardiovascular Surgery Database 2017-2018. 1.
Yasutaka Hirata1, Norimichi Hirahara2, Arata Murakami3
1Department of Cardiac Surgery, The University of Tokyo School of Medicine, Tokyo, Japan.
Insights
Mortality rates for congenital heart surgery in Japan (2017-2018) show low risk for simple repairs and higher risk for complex procedures. These findings provide a benchmark for national and international comparisons.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Public Health
Background:
- Congenital heart disease (CHD) necessitates surgical intervention, with outcomes varying by procedure complexity.
- Establishing national benchmarks for surgical mortality and morbidity is crucial for quality improvement.
Purpose of the Study:
- To analyze mortality and morbidity associated with congenital heart surgery in Japan between 2017 and 2018.
- To compare outcomes across different surgical procedures and risk categories.
Main Methods:
- Utilized data from the Japan Cardiovascular Surgery Database (2017-2018).
- Focused on the 20 most frequent congenital heart surgeries.
- Classified procedures using the Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery (STS-EACTS) congenital heart surgery mortality categories.
Main Results:
- Mortality rates for simple repairs (e.g., atrial septal defect) were 0%.
- Complex procedures showed mortality rates ranging from 2% to 15.7% (e.g., Norwood procedure).
- Outcomes within STS-EACTS categories 1-5 were comparable to international benchmarks.
Conclusions:
- Surgical outcomes for CHD in Japan demonstrate a spectrum of risk based on procedure complexity.
- These data serve as a vital reference for evaluating national trends and international comparisons.
- Continuous monitoring of mortality and morbidity is essential for advancing pediatric cardiac surgery.
Objectives:
We aimed to analyze the mortality and morbidity associated with congenital heart surgery in Japan.
Methods:
Data on congenital heart surgeries performed between January 2017 and December 2018 were obtained from Japan Cardiovascular Surgery Database. The 20 most frequent procedures were selected, and mortalities and major morbidities associated with the procedures were analyzed. All procedures were classified into Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery Congenital Heart Surgery mortality categories, and mortalities in each category were also analyzed.
Results:
The mortality rates in atrial septal defect repair and ventricular septal repair were 0% and 0.2%, respectively. The mortality rates in more complex cases (tetralogy of Fallot repair, complete atrioventricular repair, bidirectional Glenn, and total cavopulmonary connection) were 2%-3%. The mortality rates in systemic-to-pulmonary shunt, total anomalous pulmonary venous connection repair, and the Norwood procedure were 4.9%, 11.1%, and 15.7%, respectively, which were not different from those reported in 2015-2016. The mortalities according to the Society of Thoracic Surgeons-European Association for Cardiothoracic Surgery categories 1-5 were 0.3%, 2.7%, 2.9%, 5.9%, and 15.5%, respectively, and comparable to those of the Society of Thoracic Surgeons database (2013-2016).
Conclusion:
The mortality rates and frequency of complications in major surgical procedures for congenital heart disease in Japan in 2017-2018 will play an important role as a basis for trends in Japan and for comparison with results from other countries.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy V: Interprofessional Care
Mitral Stenosis III: Medical Management

